Department of Human Genetics, Ruhr-University Bochum, Bochum, Germany.
Eur J Hum Genet. 2011 May;19(5):520-4. doi: 10.1038/ejhg.2010.239. Epub 2011 Jan 19.
Mutations in the gene encoding smooth muscle cell alpha actin (ACTA2) have recently been shown to cause familial thoracic aortic aneurysms leading to type A dissections (TAAD) and predispose to premature stroke and coronary artery disease. In order to further explore the role of ACTA2 variations in the pathogenesis of TAAD, we sequenced the coding regions of this gene in 40 unrelated German patients with TAAD (with (n=21) or without (n=19) clinical features suggestive of Marfan syndrome). All patients had previously tested negative for mutations in the FBN1 and TGFBR2 genes. We identified three novel ACTA2 mutations and mapped them on a three-dimensional model of actin. Two mutations affect residues within (M49V) or adjacent to (R39C), the DNAse-I-binding loop within subdomain 2 of alpha actin. They were observed in families with recurrent aortic aneurysm (R39C) or aortic dissection (M49V). The third mutation causes an exchange in the vicinity of the ATP-binding site (G304R) in a patient thought to have isolated TAAD. None of the affected individuals had clinical features typical for Marfan syndrome, and no case of premature stroke or coronary artery disease was reported from the affected families. In conclusion, we underscore the role of ACTA2 mutations in nonsyndromic TAAD and suggest that ACTA2 should be included in the genes routinely investigated for syndromic and nonsyndromic TAAD. Detailed clinical investigations of additional families are warranted to further explore the full range of phenotypic signs associated with the three novel mutations described here.
最近的研究表明,编码平滑肌细胞α肌动蛋白(ACTA2)的基因突变可导致家族性胸主动脉瘤,进而导致 A 型夹层(TAAD),并易导致早发性中风和冠状动脉疾病。为了进一步探讨 ACTA2 变异在 TAAD 发病机制中的作用,我们对 40 例无关联的德国 TAAD 患者(有(n=21)或无(n=19)提示马凡综合征的临床特征)的该基因编码区进行了测序。所有患者先前均已排除 FBN1 和 TGFBR2 基因突变。我们鉴定出三种新的 ACTA2 突变,并对其进行了映射,以构建肌动蛋白的三维模型。两种突变影响亚基 2 内的(M49V)或临近的(R39C)残基,这些残基位于 DNAse-I 结合环内。这些突变发生在具有复发性主动脉瘤(R39C)或主动脉夹层(M49V)的家族中。第三种突变发生在一位被认为患有孤立性 TAAD 的患者附近的 ATP 结合位点附近(G304R)。受影响的个体均无马凡综合征的典型临床特征,也无早发性中风或冠状动脉疾病的病例报告。总之,我们强调了 ACTA2 突变在非综合征性 TAAD 中的作用,并建议 ACTA2 应包含在用于综合征性和非综合征性 TAAD 的常规基因检测中。需要对更多的家族进行详细的临床研究,以进一步探讨与这里描述的三种新突变相关的全部表型标志。